NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (Avenue), a company focused on the development of intravenous (IV) tramadol for the U.S. market, today announced ...
Please provide your email address to receive an email when new articles are posted on . Avenue Therapeutics announced the FDA has issued a second complete response letter regarding the new drug ...
Results from a Phase 3 study of intravenous (IV) tramadol showed that the treatment was beneficial for patients with moderate to moderately severe postoperative pain following bunionectomy surgery. In ...
MIAMI, April 17, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies ...
IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy. The road for Avenue Therapeutics' regulatory submission for ...
NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today ...
An intravenous (IV) injection is an injection of a medication or another substance into a vein and directly into the bloodstream. It is one of the fastest ways to get a drug into the body, often ...
Injections deliver liquid medications, fluids, or nutrients directly into a person’s body. Different types of injections include intravenous, intramuscular, subcutaneous, intraosseous, and intradermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results